Adial Pharmaceuticals Warrant
ADILW
ADILW was delisted on the 27th of July, 2023.
2 hedge funds and large institutions have $1.88K invested in Adial Pharmaceuticals Warrant in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
29% more capital invested
Capital invested by funds: $1.45K → $1.88K (+$426)
0% more funds holding
Funds holding: 2 → 2 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$139 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Ameriprise
Minneapolis,
Minnesota
| $1.3K | – | – | – |
|
|
WAM
2
Wolverine Asset Management
Chicago,
Illinois
| $578 | -$139 | -2,400 | -13% |
|
ADILW Hedge Fund Activity: Q1 2023 in Review
2 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals Warrant (ADILW) for Q1 2023, worth a combined $1.88K — up 29% from $1.45K a quarter earlier.
Fund positioning in ADILW was balanced in Q1 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Wolverine Asset Management, cutting an estimated $139.
- 2 institutional investors held Adial Pharmaceuticals Warrant (ADILW) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $1.88K of Adial Pharmaceuticals Warrant stock for Q1 2023, up 29% quarter-over-quarter.
- 0 funds opened new Adial Pharmaceuticals Warrant positions in Q1 2023 and 0 closed out.
- The largest Adial Pharmaceuticals Warrant seller in Q1 2023 was Wolverine Asset Management, an estimated $139 sold.
Based on aggregated 13F filings for Q1 2023.